Leonteq AMC arguments vs. UBS AMC solutions
Leonteq is more flexible in terms of investment strategy (discretionary), while UBS requires very clear limits in the investment strategy (predefined weightings).
AMCs on structured products could be implemented more easily as Leonteq accepts smaller structured products, e.g. CLNs of CHF 400-500k, while UBS requires CHF 1-1.5 million per structured product.
Leonteq can issue AMCs on cryptocurrencies.
The client faces UBS' issuance risk, while Leonteq can offer Triparty Collateral Management (TCM) and offset this risk.
1 View